HIMS Hims Hers Health Inc
Company Analysis
Latest News
🟢 HIMS is trading 5% up today ahead of Q1 earnings and weight-loss updates
HIMS is trading at $29.81 (+5%) in pre-market action, building on last week's 10% gain as investors anticipate the company's Q1 2026 earnings report scheduled...
Hims & Hers Health Inc Q1 2026 Earnings Preview: What Analysts Expect on May 11, 2026
Hims & Hers Health Inc is projected to report Q1 2026 revenue of $616.9 million and earnings per share of $0.04, as the stock currently trades around $28.27...
🟢 Hims & Hers is trading 11% up today rebounding from Amazon selloff ahead of Q1 earnings
HIMS is trading at $28.36 (+10.56%) as shares stage a sharp rebound from yesterday's selloff triggered by Amazon's entry into the telehealth weight-loss...
🟢 HIMS is trading 5.5% up today as it rebounds from Amazon-driven selloff ahead of Q1 earnings
HIMS is trading at $27.07 (+5.5%) as of May 8, 2026, rebounding sharply from a 4.6% decline in the prior session triggered by concerns over Amazon's entry into...
Hims Bounces 4% After Amazon-Fueled Selloff, but Can a Subscription Model Survive the Retail Giant's GLP-1 Blitz?
Shares of Hims & Hers Health snapped back $26.71, up 4.1%, on May 8 after tumbling 4.6% the prior session — a whipsaw that captures Wall Street's confusion...
🟢 HIMS is trading 4.1% up today as investors reassess Amazon Pharmacy competition
HIMS is trading at $26.71, up 4.1% as investors reassess the competitive impact of Amazon Pharmacy's GLP-1 expansion. • The stock is rebounding sharply from a...
Hims & Hers Shares Slide 5%, Pressured by Amazon’s GLP-1 Delivery Expansion
Shares of Hims & Hers Health (HIMS) dropped 5% on Thursday. This decline follows Amazon Pharmacy’s expansion of same-day delivery for GLP-1 weight-loss drugs...
🔴 HIMS is trading 5% down today as investors weigh AI Labs launch
HIMS is trading at $25.48 (-5.23%) following the launch of Labs AI as investors question whether the company's AI healthcare ambitions justify the recent...
Labs AI Launches, Stock Drops: Can Hims & Hers Convince Wall Street That AI Is Worth Paying For?
Shares of Hims & Hers Health fell 4% to $25.79 on a day the company unveiled a splashy new product, raising a pointed question: is the telehealth firm's AI...
🔴 HIMS is trading 4% down today despite the launch of its Labs AI care agent
HIMS is trading at $25.79 (-4%) as the stock underperforms the broader technology sector despite the debut of its new AI-powered care platform. • The company...
🔴 HIMS Drops 4% Despite Launch of New "Labs AI" Platform
Hims & Hers (HIMS) is trading down over 4% to $25.79, underperforming a broadly stronger technology market. The decline occurs on the same day the company...
🔴 HIMS falls 4%, extending losses after FDA proposes new rules on compounded GLP-1 drugs
Hims & Hers Health (HIMS) is trading down ~4% to $26.17, continuing its decline following recent news of proposed regulatory changes by the U.S. Food and Drug...
Hims & Hers Faces Lawsuits Over Data Security and Privacy Failures
Hims & Hers Health faces multiple class-action lawsuits alleging data security and privacy failures. The legal actions claim the company mishandled data...
Hims & Hers Discloses Support Data Breach, Medical Records Remain Secure
Hims & Hers Health, Inc. confirmed a data breach involving a third-party customer service platform. The company detected suspicious activity on February 5,...